SPINOCEREBELLAR ATAXIA 6 (SCA6) DNA DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited    
The SCA6 DNA Detection test identifies pathogenic CAG repeat expansions in the CACNA1A gene, which cause Spinocerebellar Ataxia Type 6. This adult-onset neurodegenerative disorder leads to progressive balance problems, unsteady gait, coordination difficulties, and visual disturbances. Metropolis Healthcare performs accurate molecular analysis using EDTA blood to determine the exact repeat size. Early confirmation supports clinical management, prognosis evaluation, and essential genetic counseling for families

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,275.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0005

Frequently Asked Questions (FAQ's):

What does the SCA6 DNA detection test check for?
It detects CAG repeat expansions in the CACNA1A gene linked to Spinocerebellar Ataxia Type 6.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques to measure repeat size precisely from EDTA blood.

Who should consider taking this test?
People with symptoms of ataxia or those with a known family history of SCA6.

What type of sample is required?
An EDTA blood sample is required for DNA extraction and genetic evaluation.

Does this test confirm the diagnosis?
Yes, detection of an expanded CAG repeat confirms SCA6 genetically.

Is any preparation needed before sample collection?
No fasting or specific preparation is necessary.

How do the results help in patient care?
They guide diagnosis, monitoring, supportive therapy, and genetic counseling.

Can family members be tested at Metropolis Healthcare?
Yes, Metropolis Healthcare offers predictive and targeted testing for at-risk relatives once the mutation is identified

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab